Literature DB >> 3346075

Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity.

J R Perfect1, M M Hobbs, D L Granger, D T Durack.   

Abstract

The functional abilities of macrophages from cerebrospinal fluid (CSF) have so far been little studied. We examined the acquisition of activation characteristics by CSF macrophages during the course of experimental cryptococcal meningitis. CSF macrophages developed the ability for increased reactive oxidative intermediate (H2O2) production and tumor and fungal cytotoxicity. Despite having been activated, CSF macrophages could not inhibit the growth of Cryptococcus neoformans in vitro. Immunosuppression with cyclosporine, which eliminates the natural resistance of rabbits to cryptococcal meningitis, did not prevent or diminish H2O2 production by CSF macrophages but did reduce their tumoricidal activity. Activation of CSF macrophages appears to be an integral part of the central nervous system immune response to C. neoformans in this model, but alone is insufficient to eliminate C. neoformans from the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346075      PMCID: PMC259380          DOI: 10.1128/iai.56.4.849-854.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms.

Authors:  W D Biggar; S Buron; B Holmes
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  ORIGIN OF BRAIN MACROPHAGES IN THE MOUSE.

Authors:  B W KONIGSMARK; R L SIDMAN
Journal:  J Neuropathol Exp Neurol       Date:  1963-10       Impact factor: 3.685

3.  Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis.

Authors:  J W Prineas; R G Wright
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

4.  In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.

Authors:  R P Lisak; B Zweiman
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

Review 5.  Classification of cells in the cerebrospinal fluid. A review.

Authors:  A Guseo
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

6.  Entry of labeled monocytic cells into the central nervous system.

Authors:  U Roessmann; R L Friede
Journal:  Acta Neuropathol       Date:  1968-06-07       Impact factor: 17.088

Review 7.  The concept of the activated macrophage.

Authors:  R J North
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

8.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

9.  Macrophages migration through the brain parenchyma to the perivascular space following particle ingestion.

Authors:  P E McKeever; J D Balentine
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

10.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

View more
  18 in total

Review 1.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

2.  Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.

Authors:  M M Hobbs; J R Perfect; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.

Authors:  Thomas H Rude; Dena L Toffaletti; Gary M Cox; John R Perfect
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

Authors:  J R Perfect; D L Toffaletti; T H Rude
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Cryptococcus neoformans gene expression during experimental cryptococcal meningitis.

Authors:  B R Steen; S Zuyderduyn; D L Toffaletti; M Marra; S J M Jones; J R Perfect; J Kronstad
Journal:  Eukaryot Cell       Date:  2003-12

8.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

Authors:  L de Repentigny; S Petitbois; M Boushira; E Michaliszyn; S Sénéchal; N Gendron; S Montplaisir
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.